Clene Inc. (CLNN) Social Stream
Clene Inc (CLNN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CLNN.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-12 | 5 | $25.001 | $15 | $20.4 | $3.2 | 537.5% |
2022-01-20 | 5 | $25.001 | $10 | $19.4 | $3.2 | 506.25% |
2022-02-14 | 5 | $25.001 | $10 | $19.2 | $3.2 | 500% |
2022-03-15 | 4 | $24 | $10 | $17.75 | $3.2 | 454.69% |
The Trend in the Analyst Price Target
Over the past 30 weeks, CLNN's average price target has gone down $5.
CLNN reports an average of 311.4% for its upside potential over the past 49 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2021-04-03 | 0 | 25.000 | 24 | 24.50 | 13.00 | 88.46% |
2021-08-19 | 2 | 25.000 | 18 | 22.75 | 7.34 | 209.95% |
2021-09-11 | 2 | 25.000 | 18 | 22.75 | 7.55 | 201.32% |
2022-01-20 | 4 | 25.001 | 10 | 19.40 | 2.72 | 613.24% |
2022-03-15 | 4 | 24.000 | 10 | 17.75 | 2.42 | 633.47% |
CLNN Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 151 days, CLNN's average broker recommendation rating improved by 0.8.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- CLNN has a greater upside potential (average analyst target price relative to current price) than 578.21% of all US stocks.
- CLNN has a lower variance in analysts' estimates than -394.77% of all US stocks.
- CLNN has a higher number of analysts covering the stock than 179.28% of Pharmaceutical Products stocks.
- CLNN has a greater average analyst price target than 188.94% of Healthcare stocks.
Stocks similar to Clene Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CKPT, CINC, and CELU.
Is CLNN a Buy, Hold or Sell? See the POWR Ratings now!